Abbott Laboratories (ABT) Q2 2026 Earnings Report
CH:ABT Q2 2026 EPS Results
- Actual EPS
- CHF 1.08
- Consensus EPS
- CHF 1.05
- Beat/Miss
- Beat by +CHF 0.03
- One Year Ago EPS
- CHF 1.04
CH:ABT Q2 2026 Revenue Results
- Actual Revenue
- CHF 10.37B
- Expected Revenue
- CHF 10.31B
- Beat/Miss
- Beat by +CHF 60.54M
- YoY Revenue Growth
- +13.02%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 07/16/2026
- Time
- Before Open
- Conference Call
- Thursday, July 16, 2026
CH:ABT Upcoming Earnings
Abbott Laboratories's next earnings date is estimated for January 27, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
CH:ABT Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:ABT Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Jan 27, 2027 | 2026 (Q4) | 1.35- | 1.24 | ― | ― |
| Oct 21, 2026 | 2026 (Q3) | 1.171.17 | 1.07 | 9.23% (+0.10) | |
| Jul 16, 2026 | 2026 (Q2) | 1.051.08 | 1.04 | 3.97% (+0.04) | |
| Apr 16, 2026 | 2026 (Q1) | 0.940.95 | 0.9 | 5.50% (+0.05) | |
| Jan 22, 2026 | 2025 (Q4) | 1.231.24 | 1.1 | 11.94% (+0.13) | |
| Oct 15, 2025 | 2025 (Q3) | 1.071.07 | 1 | 7.44% (+0.07) | |
| Jul 17, 2025 | 2025 (Q2) | 1.031.04 | 0.94 | 10.53% (+0.10) | |
| Apr 16, 2025 | 2025 (Q1) | 0.880.90 | 0.81 | 11.22% (+0.09) | |
| Jan 22, 2025 | 2024 (Q4) | 1.111.10 | 0.98 | 12.61% (+0.12) | |
| Oct 16, 2024 | 2024 (Q3) | 0.991.00 | 0.94 | 6.14% (+0.06) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed